Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Acquiring Company
Bristol Myers Squibb
Acquired Company
AstraZeneca
LawrencevilleManufacturingBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaDescription
AstraZeneca is in talks to merge with Bristol Myers Squibb in a potential deal valued at $400 billion. If completed, this would mark one of the largest mergers in the pharmaceutical industry. The discussions have been ongoing for several months, highlighting the strategic interests of both companies.
Related People
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed